Cardiologist and Patient Care author Payal Kohli, MD offers snap shots of 6 influential studies that will affect the future of AF diagnosis and treatment.
2017 was a roller-coaster year in cardiology research with trials such as the CAD sham-controlled ORBITA trial turning our beliefs about revascularization upside down and the new ACC/AHA hypertension guidelines generating controversy from the community given the far-reaching implications suggested. As a sampling, here is Part 1 of my top 6 study picks in the world of atrial fibrillation that I reviewed on Patient Care during 2017 and why I think they are important.For Part II, please click here.Â
Biden Administration Announces First 10 Prescription Drugs Slated for Price Negotiations
August 29th 2023The first 10 drugs identified for negotiations under the Inflation Reduction Act include several well advertised agents indicated to treat diabetes, heart failure, and other chronic diseases.